Dates,Efficacy-and-safety-of-pembrolizumab-in-patients,cncr35601-sup-0001-suppl-data
2024-11-11,2,4
2024-11-12,3,0
2024-11-13,0,0
2024-11-14,2,0
2024-11-15,2,0
2024-11-16,0,0
2024-11-17,4,0
2024-11-18,0,0
2024-11-19,3,0
2024-11-20,0,0
2024-11-21,0,0
2024-11-22,0,0
2024-11-23,2,0
2024-11-24,1,0
2024-11-25,0,1
2024-11-26,2,0
2024-11-27,1,0
2024-11-28,0,0
2024-11-29,0,0
2024-11-30,0,0
2024-12-01,0,0
2024-12-02,4,0
2024-12-03,0,1
2024-12-04,2,0
2024-12-05,0,0
2024-12-06,0,0
2024-12-07,0,0
2024-12-08,0,0
2024-12-09,0,0
2024-12-10,0,0
2024-12-11,0,0
2024-12-12,1,0
2024-12-13,0,0
2024-12-14,0,0
2024-12-15,0,0
2024-12-16,0,0
2024-12-17,0,0
2024-12-18,2,0
2024-12-19,0,0
2024-12-20,0,0
2024-12-21,0,0
2024-12-22,0,0
2024-12-23,1,0
2024-12-24,0,0
2024-12-25,0,0
2024-12-26,0,0
2024-12-27,0,0
2024-12-28,0,0
2024-12-29,0,0
2024-12-30,0,0
2024-12-31,0,0
2025-01-01,0,0
2025-01-02,0,0
2025-01-03,0,0
2025-01-04,0,0
2025-01-05,0,0
2025-01-06,0,0
2025-01-07,0,0
2025-01-08,0,0
2025-01-09,1,3
2025-01-10,0,0
2025-01-11,0,0
2025-01-12,2,0
2025-01-13,1,0
2025-01-14,1,0
2025-01-15,0,0
2025-01-16,3,0
2025-01-17,0,0
2025-01-18,0,0
2025-01-19,0,0
2025-01-20,0,0
2025-01-21,0,0
2025-01-22,0,2
2025-01-23,0,0
2025-01-24,1,0
2025-01-25,1,0
2025-01-26,1,0